Hypomemylating Agents Combination With eDC Therapy for Elderly Patients With Myelodysplastic Syndrome

NCT04999943 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes
Dendritic Cell
Hypomethylating Agents
Immunotherapy

Interventions

BIOLOGICAL: DC vaccine

Sponsor

Affiliated Hospital to Academy of Military Medical Sciences